Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database.

Anita M LoughlinStephanie E ChiuveGally ReznorMichael DohertyStacey A MissmerAndrea K ChomistekCheryl Enger

Published in: Pharmacoepidemiology and drug safety (2021)

Considering potentially undiagnosed adenomyosis, the prevalence of adenomyosis may be 10x higher than prior estimates based on histologically confirmed adenomyosis cases only.

Keyphrases

electronic health record
risk factors
clinical decision support
adverse drug